Table 1.
Clinical and demographic characteristics in patients undergoing exercise and dobutamine stress test
| Variable, n (%) | Exercise 45 (54) | Dobutamine 46 (56) | Total (81) | P |
|---|---|---|---|---|
| Age (years) | 57.4±9.7 | 69.72±9.14 | 64.3±11.2 | <0.001 |
| Sex (male) | 23 (51) | 26 (57) | 49 (60) | 0.408 |
| Hypertension | 10 (22) | 8 (23) | 18 (22) | 0.368 |
| Diabetes | 4 (9) | 7 (20) | 11 (14) | 0.627 |
| Dyslipidemia | 1 (2) | 3 (8) | 4 (5) | 0.457 |
| Family history | 2 (4) | 3 (8) | 5 (6) | 0.883 |
| Smoke | 13 (28) | 15 (42) | 28 (35) | 0.376 |
| VTD (ml/m2) | 59.7±4.6 | 57.4±3.9 | 58.3±4.2 | 0.298 |
| LVEF (%) | 60.1±4.9 | 58.9±4.2 | 59.6±4.6 | 0.248 |
| ATD (cm2/m2) | 10.1±1.5 | 9.4±1.2 | 9.9±1.4 | 0.306 |
| FAC (%) | 41.1±5.5 | 39.4±3.8 | 40.4±4.9 | 0.145 |
*Percentage is referred to the number of patients in the column. FAC=Fractional area change, LVEF=Left ventricular ejection fraction, LVEDV=left ventricle end diastolic volume, RVEDA=right ventricle end diastolic area